Identification Generic Name (2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE DrugBank Accession Number DB08314 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE (DB08314) ×  Close Weight Average: 267.079  Monoisotopic: 265.969090125  Chemical Formula C 10 H 7 BrN 2 O 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Biotin carboxylase Not Available Escherichia coli (strain K12) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as aryl-phenylketones. These are aromatic compounds containing a ketone substituted by one aryl group, and a phenyl group. Kingdom Organic compounds Super Class Organic oxygen compounds Class Organooxygen compounds Sub Class Carbonyl compounds Direct Parent Aryl-phenylketones Alternative Parents Benzoyl derivatives  /  Bromobenzenes  /  2,5-disubstituted oxazoles  /  Aryl bromides  /  Heteroaromatic compounds  /  Oxacyclic compounds  /  Azacyclic compounds  /  Primary amines  /  Organopnictogen compounds  /  Organobromides  /  Organic oxides  /  Hydrocarbon derivatives 
 
 
  show 2 more Substituents 2,5-disubstituted 1,3-oxazole  /  Amine  /  Aromatic heteromonocyclic compound  /  Aryl bromide  /  Aryl halide  /  Aryl-phenylketone  /  Azacycle  /  Azole  /  Benzenoid  /  Benzoyl  /  Bromobenzene  /  Halobenzene  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxide  /  Organobromide  /  Organohalogen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organopnictogen compound  /  Oxacycle  /  Oxazole  /  Primary amine 
 
 
  show 15 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key YDCMMVTWXORJGO-UHFFFAOYSA-N InChI InChI=1S/C10H7BrN2O2/c11-7-3-1-2-6(4-7)9(14)8-5-13-10(12)15-8/h1-5H,(H2,12,13) IUPAC Name 5-(3-bromobenzoyl)-1,3-oxazol-2-amine SMILES NC1=NC=C(O1)C(=O)C1=CC(Br)=CC=C1 References General References Not Available External Links PubChem Compound 25271554 PubChem Substance 99444785 ChemSpider 25057748 BindingDB 32639 ChEMBL CHEMBL1234904 ZINC ZINC000053683069 PDBe Ligand OA1 PDB Entries 2w6m Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.303 mg/mL ALOGPS logP 2.05 ALOGPS logP 1.92 Chemaxon logS -3 ALOGPS pKa (Strongest Acidic) 13.58 Chemaxon pKa (Strongest Basic) 1.32 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 69.12 Å 2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 59.02 m 3 ·mol -1 Chemaxon Polarizability 22.1 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9963 Blood Brain Barrier + 0.9883 Caco-2 permeable + 0.5 P-glycoprotein substrate Non-substrate 0.9009 P-glycoprotein inhibitor I Non-inhibitor 0.9129 P-glycoprotein inhibitor II Non-inhibitor 0.845 Renal organic cation transporter Non-inhibitor 0.902 CYP450 2C9 substrate Non-substrate 0.8664 CYP450 2D6 substrate Non-substrate 0.8725 CYP450 3A4 substrate Non-substrate 0.728 CYP450 1A2 substrate Inhibitor 0.914 CYP450 2C9 inhibitor Non-inhibitor 0.5923 CYP450 2D6 inhibitor Non-inhibitor 0.8926 CYP450 2C19 inhibitor Non-inhibitor 0.5668 CYP450 3A4 inhibitor Non-inhibitor 0.859 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5114 Ames test Non AMES toxic 0.7072 Carcinogenicity Non-carcinogens 0.8916 Biodegradation Not ready biodegradable 0.9888 Rat acute toxicity 2.4152 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9491 hERG inhibition (predictor II) Non-inhibitor 0.9122    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Biotin carboxylase Kind Protein Organism Escherichia coli (strain K12) Pharmacological action Unknown General Function Metal ion binding Specific Function This protein is a component of the acetyl coenzyme A carboxylase complex; first, biotin carboxylase catalyzes the carboxylation of the carrier protein and then the transcarboxylase transfers the ca... Gene Name accC Uniprot ID P24182 Uniprot Name Biotin carboxylase Molecular Weight 49320.32 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52 